Taken together, our results agree with the hypothesis that the 50-kDa isoform that we found to be elevated in CSF and plasma in AD patients corresponds to an inactive form of ADAM10, as demonstrated by the activity test. This evidence concerns the gene ADAM10 and Alzheimer disease.